We have also examined FcμR expression in CLL patients using receptor-specific mAbs, finding marked elevation of serum titers of FcμR in many CLL patients, but not healthy individuals (10), except for one person who developed high titers of anti-nuclear Abs two years later (2). Here, FCMR is linked to B-cell chronic lymphocytic leukemia.